Adlai Nortye (ANL) EBT (2024)

Adlai Nortye's (ANL) quarterly EBT came in at -$10000.0 in Q4 2024.

Adlai Nortye (ANL) EBT (2024) Analysis & Trends

Adlai Nortye (ANL) has 1 years of EBT data on file, last reported at -$10000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -36.97 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 259.22 Mn
4 NuCana 279.75 Bn 279.75 Bn - -3.49 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.25 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 831.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 541.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 Adlai Nortye 1.27 Bn 1.26 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -10,000.00